![]() |
|
|
Vol. 288, Issue 1, 188-197, January 1999
Departments of
Psychiatry and Behavioral Science (H.E.J., R.R.G.)
and
Neuroscience (R.R.G.), Johns Hopkins University School of Medicine,
Baltimore, Maryland
The subjective and physiological effects of intravenously administered
cocaine and nicotine were compared in 10 cigarette-smoking cocaine
abusers. Subjects abstained from smoking at least 8 h before each
session. Under double blind conditions, subjects received placebo,
cocaine (10, 20, and 40 mg/70 mg), or nicotine (0.75, 1.5, 3.0 mg/70
kg) in mixed order. Physiological and subjective data were collected
before and repeatedly after each intravenous drug administration.
Subjects also completed a drug versus money multiple-choice procedure
in which they chose between that day's drug and 44 monetary values.
Both drugs increased blood pressure and heart rate and decreased skin
temperature. Nicotine showed a more rapid onset of subjective effects
than cocaine. Overall, although both cocaine and nicotine increased
subjective ratings of "drug effect", "rush", "good
effects", "liking", "high", and "stimulated", only
nicotine increased ratings of "bad effects" and "jittery".
Although the highest nicotine dose produced greater effects than the
highest cocaine dose on most subjective measures, the highest cocaine
dose produced somewhat greater ratings of drug liking. At doses that
produced comparable ratings of drug effect (40 mg/70 kg cocaine versus
1.5 mg/70 kg nicotine), cocaine produced significantly greater good
effects, whereas nicotine produced greater bad effects. All three
cocaine doses and the intermediate and high nicotine doses were
frequently categorized as producing effects similar to those of cocaine
or amphetamine. The drug versus money measure showed that the highest
cocaine dose was worth twice as much as the highest nicotine dose.
Thus, intravenous cocaine and nicotine can be differentiated by their subjective and reinforcing effects.
This article has been cited by other articles:
![]() |
J. H. Mendelson, M. B. Sholar, N. H. Mutschler, M. Jaszyna-Gasior, N. V. Goletiani, A. J. Siegel, and N. K. Mello Effects of Intravenous Cocaine and Cigarette Smoking on Luteinizing Hormone, Testosterone, and Prolactin in Men J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 339 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cardenas, L. K. Tremblay, C. A. Naranjo, N. Herrmann, M. Zack, and U. E. Busto Brain Reward System Activity in Major Depression and Comorbid Nicotine Dependence J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1265 - 1271. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Garrett and R. R. Griffiths Intravenous Nicotine and Caffeine: Subjective and Physiological Effects in Cocaine Abusers J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 486 - 494. [Abstract] [Full Text] |
||||
![]() |
K. A. Perkins, D. Gerlach, M. Broge, J. E. Grobe, M. Sanders, C. Fonte, J. Vender, C. Cherry, and A. Wilson Dissociation of Nicotine Tolerance from Tobacco Dependence in Humans J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 849 - 856. [Abstract] [Full Text] |
||||